Sleep Disorders Trial, Recruiting NCT06732284 Sponsor: Centre Hospitalier Universitaire de Nīmes Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06732284
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have given your free and informed agreement to take part and signed a consent form
  • You are covered by a health insurance plan
  • You are able to understand, read, and write in French
  • (For people with depression) You have been diagnosed with depression based on standard diagnostic criteria (DSM-5)
  • (For people with depression) You are suspected of having a sleep disorder that needs to be checked with a sleep study
  • (For people with depression — sleep inertia group) You score 1 or higher on specific questions (items 3 and 4) of a sleep inertia questionnaire, meaning you experience difficulty waking up or feeling alert in the morning
  • (For people with depression — no sleep inertia group) You score 0 on those same questionnaire items, meaning you do not have that difficulty waking up
  • (For healthy volunteers/controls) You have no complaints about difficulty waking up, no excessive daytime sleepiness, and no signs of depression based on standard questionnaire scores

Who may not be able to join:

  • You are currently taking part in another interventional clinical study
  • You are under legal protection or guardianship
  • You are currently taking certain medications — including stimulants, sleeping pills, antidepressants, anti-anxiety medications, some epilepsy drugs, opioids, or certain other medicines — and have not stopped them for long enough before joining (confirm with trial site for specific medicines and timing)
  • You have a brain or nervous system condition such as Parkinson's disease, dementia, epilepsy, or a history of head injury with loss of consciousness
  • You have had a cancer requiring treatment in the 12 months before the screening visit
  • You have another significant medical or mental health condition (other than depression, for those in the depression group) that the study doctor believes could affect the results
  • You have a history of a suicide attempt, or have had thoughts of suicide in the past month
  • You have had ongoing heavy alcohol use or drug misuse in the past 6 months
  • You have a diagnosed disorder of your sleep-wake body clock rhythm, or are not getting enough sleep according to standard sleep disorder criteria (confirm with trial site)
  • You are pregnant, have recently given birth, or are breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elisa EVANGELISTA, CHU de Nimes

Phone: 04.66.68.39.00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de Nīmes
Registry
ClinicalTrials.gov
Start date
4 November 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Level of vigilance and sustained attention before and after sleep between groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov